NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Sintx Technologies, Inc. SINT
13 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.0M
▼ 64.7% vs FY2024
EPS · FY25
$-6.16
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-303.8%
Net margin · FY25
-1018.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.0M
Revenue, FY2025 · full 13-year series below
Revenue
Net income
The company lost 1018 cents on every revenue dollar this year.
Per share
USD -6.16
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-303.8%
Return on equity, FY2025
ROE
Operating margin-1053.1%
Net margin-1018.1%
Return on assets-109.6%
Each USD of equity lost 304 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD -4.2M
Share of profit-0.0%
Consecutive raises—
Growth
+11.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−13.3%
+11.4%
−25.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.00B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 9.5M
total assets, end of FY2025
Total assetsUSD 9.5M
EquityUSD 2.9M
CashUSD 4.1M
Gross debtUSD 7,000.00
Net debtUSD -4.1M
Current ratio1.51×
The company holds more cash than debt.
History
13 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
·
·
·
·
·
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−6.16
−15.19
−624.47
−60.81
−39.91
−1.08
−5.69
−76.73
−3.13
−13.63
−66.05
−39.93
−15.52
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−303.8
−174.1
−114.1
−105.1
−43.3
−45.3
−70.5
−125.0
−111.9
−115.5
−225.2
·
·
Shares out B
0.00
0.00
0.00
0.00
0.00
0.02
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
52 of 52
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed